Primary Recipient

REGENX BIOSCIENCES, LLC

Amount

$2,822,695.00

Award Date

7/26/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The goal of this project is to develop a gene therapeutic for retinitis pigmentosa (RP). RP is the most common inherited form of blindness, and is characterized by photoreceptor loss, leading to a progressive loss of peripheral as well as night vision.

Recipients Connected to Award

Recipient	Role	Amount
REGENX BIOSCIENCES, LLC	Primary recipient	$1,907,246.00
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA	Sub-recipient	$915,449.00